Home › Funds › Meridiem Capital Partners LP › ELV

Meridiem Capital Partners LP position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Meridiem Capital Partners LP reported holding 96,663 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$37.6M, representing 1.76% of its reported portfolio and ranking #17 among its reported holdings. Meridiem Capital Partners LP has disclosed ELV holdings in 2 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)96.66K sh
Reported value held$37.58M
Portfolio Weight1.76%
First reportedQ1 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Meridiem Capital Partners LP's ELV position evolved

Meridiem Capital Partners LP first disclosed a stake in ELV in Q1 2026 at 87,947 shares (US$25.7M). The position peaked in Q3 2026 at 96,663 shares, worth US$37.6M. Across 2 filings, Meridiem Capital Partners LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 96,663 shares valued at US$37.6M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 87.95K $25.75M New
Q3 2026 96.66K $37.58M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.31B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Meridiem Capital Partners LP held ELV?

Meridiem Capital Partners LP has disclosed ELV holdings in 2 of the last 3 reported quarters, going back to Q1 2026.

What is Meridiem Capital Partners LP's current position in ELV?

As of Q3 2026, Meridiem Capital Partners LP holds 96.66K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $37.58M, representing 1.76% of its reported portfolio and ranking #17.

Has Meridiem Capital Partners LP been buying or selling ELV?

In the latest 13F filing (Q3 2026), Meridiem Capital Partners LP newly opened its position in ELV. The position peaked in Q3 2026 at 96.66K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.